c-Jun N-TERMINAL KINASE BINDING DOMAIN-DEPENDENT PHOSPHORYLATION OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 AND MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 AND BALANCING CROSS-TALK BETWEEN c-Jun N-TERMINAL KINASE AND EXTRACELLULAR SIGNAL-REGULATED KINASE PATHWAYS IN CORTICAL NEURONS

被引:37
|
作者
Repici, M. [2 ]
Mare, L. [2 ]
Colombo, A. [1 ]
Ploia, C. [1 ]
Sclip, A. [1 ]
Bonny, C. [3 ]
Nicod, P. [3 ]
Salmona, M. [1 ]
Borsello, T. [1 ,2 ]
机构
[1] Ist Ric Farmacol Mario Negri, Biol Neurodeg Disorders Lab, Neuronal Death & Neuroprotect Unit, I-20156 Milan, Italy
[2] Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland
[3] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
JNK; MKK4; MKK7; ERK; MEK1; D-JNKI1; PEPTIDE INHIBITOR; CELL-DEATH; DOCKING SITES; NH2-TERMINAL KINASE; CEREBRAL-ISCHEMIA; DOWN-REGULATION; HEARING-LOSS; JNK; TRANSDUCTION; INJURY;
D O I
10.1016/j.neuroscience.2008.11.049
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The c-Jun N-terminal kinase (JNK) is a mitogen-activated protein kinase (MAPK) activated by stress-signals and involved in many different diseases. Previous results proved the powerful effect of the cell permeable peptide inhibitor D-JNKI1 (D-retro-inverso form of c-Jun N-terminal kinase-inhibitor) against neuronal death in CNS diseases, but the precise features of this neuroprotection remain unclear. We here performed cell-free and in vitro experiments for a deeper characterization of D-JNKI1 features in physiological conditions. This peptide works by preventing JNK interaction with its c-Jun N-terminal kinase-binding domain (JBD) dependent targets. We here focused on the two JNK upstream MAPKKs, mitogen-activated protein kinase kinase 4 (MKK4) and mitogen-activated protein kinase kinase 7 (MKK7), because they contain a JBD homology domain. We proved that D-JNKI1 prevents MKK4 and MKK7 activity in cell-free and in vitro experiments: these MAPKK could be considered not only activators but also substrates of JNK. This means that D-JNKI1 can interrupt downstream but also upstream events along the JNK cascade, highlighting a new remarkable feature of this peptide. We also showed the lack of any direct effect of the peptide on p38, MEK1, and extracellular signal-regulated kinase (ERK) in cell free, while in rat primary cortical neurons JNK inhibition activates the MEK1-ERK-Ets1/c-Fos cascade. JNK inhibition induces a compensatory effect and leads to ERK activation via MEK1, resulting in an activation of the survival pathway(MEK1/ERK) as a consequence of the death pathway-(JNK) inhibition. This study should hold as an important step to clarify the strong neuroprotective effect of D-JNKI1. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:94 / 103
页数:10
相关论文
共 50 条
  • [41] Molecular cloning of mitogen-activated protein ERK kinase kinases (MEKK) 2 and 3 - Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase
    Blank, JL
    Gerwins, P
    Elliott, EM
    Sather, S
    Johnson, GL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) : 5361 - 5368
  • [42] Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis
    Schett, G
    Tohidast-Akrad, M
    Smolen, JS
    Schmid, BJ
    Steiner, CW
    Bitzan, P
    Zenz, P
    Redlich, K
    Xu, QB
    Steiner, G
    ARTHRITIS AND RHEUMATISM, 2000, 43 (11): : 2501 - 2512
  • [43] Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7
    Fleming, Y
    Armstrong, CG
    Morrice, N
    Paterson, A
    Goedert, M
    Cohen, P
    BIOCHEMICAL JOURNAL, 2000, 352 : 145 - 154
  • [44] Involvement of the mitogen-activated protein kinase c-Jun NH2-terminal kinase 1 in thrombus formation
    Kauskot, Alexandre
    Adam, Frederic
    Mazharian, Alexandra
    Ajzenberg, Nadine
    Berrou, Eliane
    Bonnefoy, Arnaud
    Rosa, Jean-Philippe
    Hoylaerts, Marc F.
    Bryckaert, Marijke
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (44) : 31990 - 31999
  • [45] c-Jun N-terminal kinase pathways in diabetes
    Yang, Ruojing
    Trevillyan, James M.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (12): : 2702 - 2706
  • [46] Rhamnetin Is a Potent Inhibitor of Extracellular Signal-regulated Kinase 1 and c-Jun N-Terminal Kinase 1
    Jnawali, Hum Nath
    Jeon, Dasom
    Park, Young-Gun
    Lee, Eunjung
    Heo, Yong-Seok
    Kim, Yangmee
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2015, 36 (08): : 2107 - 2110
  • [47] Signal transduction by the c-Jun N-terminal kinase
    Davis, RJ
    CELLULAR RESPONSES TO STRESS, 1999, (64): : 1 - 12
  • [48] Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells.
    Chaturvedi, LS
    Koul, S
    Sekhon, A
    Bhandari, A
    Menon, M
    Koul, HK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (15) : 13321 - 13330
  • [49] Structural Optimization of a Pyridinylimidazole Scaffold: Shifting the Selectivity from p38α Mitogen-Activated Protein Kinase to c-Jun N-Terminal Kinase 3
    Ansideri, Francesco
    Macedo, Joana T.
    Eitel, Michael
    El-Gokha, Ahmed
    Zinad, Dhafer S.
    Scarpellini, Camilla
    Kudolo, Mark
    Schollmeyer, Dieter
    Boeckler, Frank M.
    Blaum, Baerbel S.
    Laufer, Stefan A.
    Koch, Pierre
    ACS OMEGA, 2018, 3 (07): : 7809 - 7831
  • [50] Activation of c-Jun N-terminal kinase stress-activated protein kinase in primary glial cultures
    Zhang, PS
    Miller, BS
    Rosenzweig, SA
    Bhat, NR
    JOURNAL OF NEUROSCIENCE RESEARCH, 1996, 46 (01) : 114 - 121